Numerous studies have demonstrated that ABCA1 was associated with the development of a variety of cancers, including colon cancer (65, 66), myeloproliferative neoplasms (67), ovarian cancer (68, 69), prostate cancer (70), and melanoma (71). Here, ABCA1 is linked to myeloproliferative disorder.